(19)
(11) EP 1 231 913 A2

(12)

(88) Date of publication A3:
20.06.2002

(43) Date of publication:
21.08.2002 Bulletin 2002/34

(21) Application number: 00951029.8

(22) Date of filing: 07.06.2000
(51) International Patent Classification (IPC)7: A61K 31/201, A61P 3/00, A61P 11/06, A61P 17/00, A61P 19/02, A61P 25/28, A61P 27/00, A61P 29/00, A61P 35/00, A61P 37/08, A61P 43/00
(86) International application number:
PCT/US0040/138
(87) International publication number:
WO 0100/3688 (18.01.2001 Gazette 2001/03)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.07.1999 US 143031 P

(71) Applicant: Pharmacia Corporation
St. Louis, MO 63167 (US)

(72) Inventors:
  • ABBAS, Zaheer
    Chesterfield, MO 63017 (US)
  • KOBOLDT, Carol
    Florissant, MO 63031 (US)

(74) Representative: Albrecht, Thomas, Dr. 
Kraus, Weisert & PartnerPatent- und RechtsanwälteThomas-Wimmer-Ring 15
80539 München
80539 München (DE)

   


(54) TREATMENT OF CYCLOOXYGENASE-2 MEDIATED DISORDERS USING CONJUGATED FATTY ACID COMPOUNDS